BNF:

1.6

Status:

Grey - after consultant/specialist initiation

Decision Date:

July 2017

Comments

GREY after gastro-consultant initiation and assessment of efficacy within a 4 week period.

See local IBS guidance

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy

search again